Table 2.
Study | n | location | years | matrix1 | Classes measured | ||||
---|---|---|---|---|---|---|---|---|---|
phthalates | phenols | PFCs | Flame retardants | PCBs & OCs | |||||
Maternal Serum (MS) | |||||||||
Abdelouahab et al. 2013 [136] | 380 | Canada | 2007–08 | MS | x | x | |||
Adlard et al. 2014 [118] | 363 | Canada, Mexico | 2005–2007 | MS | x | x | |||
Carmichael et al. 2010 [137] | 48 | USA | 2003 | MS | x | x | |||
Cheslack-Postava et al. 2013 [88] | 150 | Finland | 1991–2000 | MS | x | x | |||
Roze et al. 2009 [151] | 62 | Netherlands | 2001–02 | MS | x | x | |||
Vafeiadi et al. 2014 [95] | 1117 | Greece | 2007–08 | MS | x | x | |||
Vorkamp et al. 2014 [138] | 100 | Denmark | 2011 | MS | x | x | |||
Zota et al. 2013 [82] | 61 | USA | 2008–12 | MS | x | x | |||
Maternal urine (MU) | |||||||||
Arbuckle et al. 2014 [152] | 2000 | Canada | 2008–11 | MU | x | x | |||
Braun et al. 2012 [153] | 137 | USA | 2004–09 | MU | x | x | |||
Braun et al. 2014 [154] | 177 | USA | 2005–11 | MU | x | x | |||
Casas et al. 2011 [134] | 120 | Spain | 2004–08 | MU | x | x | |||
Tefre de Renzy-Martin et al. 2014 [132] | 200 | Denmark | 2011 | MU | x | x | |||
Ferguson et al. 2014 [155] | 107 | Mexico | 1994–2004 | MU | x | x | |||
Hoepner et al. 2013 [145] | 375 | USA | 1999–2006 | MU | x | x | |||
Phillipat et al. 2012 [133] | 191, 287 | France | 2002–06 | MU | x | x | |||
Watkins et al. 2014 [156] | 116 | Mexico | 1997–2004 | MU | x | x | |||
Weinberger et al. 2014 [157] | 72 | USA | not listed | MU | x | x | |||
Breast Milk (BM) | |||||||||
Alivernini et al. 2011 [158] | 13 | Italy | 2005–2007 | BM | x | x | |||
Croes et al. 2012 [141] | 84 | Belgium | 2009–10 | BM | x | x | |||
Gómara et al. 2011 [159] | 9 | Spain | 2005 | BM | x | x | |||
Hernik et al. 2011 [100] | 28 | Poland | 2002–05 | BM | x | x | |||
LaKind et al. 2009 [97] | 10 | USA | 2004–05 | BM | x | x | |||
Lankova et al. 2013 [55] | 50 | Czech Republic | 2010 | BM | x | x | |||
Lignell et al. 2009 [140] | 335 | Sweden | 1996–2006 | BM | x | x | |||
Park et al. 2011 [143] | 82 | USA | 2003–05 | BM | x | x | |||
Pratt et al. 2013 [160] | 109 | Ireland | 2010 | BM | x | x | |||
Raab et al. 2013 [101] | 516 | Germany | 2007–08 | BM | x | x | |||
Schlumpf et al. 2010 [121] | 54 | Switzerland | 2004–06 | BM | x | x | x | x | |
Schuhmacher et al. 2008 [144] | 15 | Spain | 2007 | BM | x | x | |||
Thomsen et al. 2010 [62] | 70 | Norway | 2001–09 | BM | x | x | x | ||
Cord Serum (CS) | |||||||||
Arbuckle et al. 2013 [139] | 126 | Canada | 2005–08 | CS | x | x | |||
Chevalier et al. 2015 [19] | 180 | France | 2002–05 | CS | x | x | x | ||
Vizcaino et al. 2011 [161] | 265 | Spain | 1997–98 | CS | x | x | |||
Placenta (P) and Amniotic Fluid (AF) | |||||||||
Leino et al. 2013 [107] | 130 | Finland | 2004–2005 | P | x | x | |||
Nanes et al. 2014 [162] | 42 | USA | not listed | P | x | x | |||
Jensen et al. 2012 [18] | 300 | Denmark | 1980–96 | AF | x | x | |||
Multiple matrices | |||||||||
Braun et al. 2014 [142] | 175 | USA | 2003–06 | MU, MS | x | x | x | x | x |
Brucker-Davis et al. 2011 [163] | 69, 84 | France | 2002–05 | BM, CS | x | x | |||
de Cock et al. 2014 [56] | 83 | Netherlands | 2011–13 | CS, BM | x | x | x | ||
Doucet et al. 2009 [164] | 52, 60 | Canada | 1998–2006 | P, fetal liver | x | x | |||
Needham et al. 2011 [57] | 15 | Faroe Islands | 2000 | MS, BM, CS, P | x | x | |||
Porpora et al. 2013 [165] | 38 | Italy | 2008–09 | MS, CS | x | x | |||
Vizcaino et al. 2014 [135] | 308, 50 | Spain | 2004–08 | MS, CS, P | x | x | |||
Woodruff et al. 2011 [2] | 268 | USA | 2003–04 | MU, MS | x | x | x | x | x |
Matrix abbreviations: MS: maternal serum; MU: maternal urine; BM: breast milk; CS: cord serum; P: placenta; AF: amniotic fluid